Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10029


The aim of this study is to assess the short term success and feasibility of ileal transposition with sleeve gastrectomy in non-morbidly obese patients with poorly controlled Type 2 Diabetes Mellitus


Inclusion Criteria: 1. Diagnosed Type 2 Diabetes for 3 to 5 years. 2. Poorly controlled blood sugar despite standard of care* as demonstrated by HbA1c 8-11 for at least 6 months and 3 office visits. Standard of care is based on the ADA (American Diabetes Association) guidelines which include nutrition, exercise, education, behavior modification and pharmacological treatment. A co-investigator endocrinologist will ensure that the above standard of care has been met. 3. BMI between 25.0 and 34.4. 4. Stable weight as determined by no more than a 3% change in body weight in the last 3 months. 5. Age between 35 and 65 (both men and women will be included). 6. Able to provide Informed Consent. 7. Able to comply with follow-up procedures. Exclusion Criteria: 1. Previous history of major abdominal surgery which may lead to a hostile abdomen. 2. Pregnancy 3. Patients who have an incurable malignant or debilitating disease 4. Serious uncorrectable impairment of coagulation (INR>1.4, PTT > + 3 secs), lungs, kidney or heart 5. Diagnosed severe eating disorder 6. Use of medication for weight loss in the last 6 months 7. Untreated endocrine disorder 8. Active peptic ulcer 9. Untreated H. pylori 10. Cognitive Impairment 11. Diabetic autonomic neuropathy 12. Symptomatic gastroparesis

Study is Available At:

Original ID:




Secondary ID:

Study Acronym:

Brief Title:

Surgical Treatment of Type 2 Diabetes in Non-Morbidly Obese Patients

Official Title:

Phase IV Study of Surgical Treatment of Type 2 Diabetes in Non-Morbidly Obese Patients

Overall Status:


Study Phase:

Phase 4



Minimum Age:

35 Years

Maximum Age:

65 Years

Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:


Oversight Authority:

United States: Institutional Review Board

Reasons Why Stopped:

Business Reasons

Study Type:


Study Design:

Endpoint Classification: Safety/Efficacy Study, In

Number of Arms:


Number of Groups:


Total Enrollment:


Enrollment Type:


Overall Contact Information

Official Name:Barry Salky, MD
Principal Investigator
Mount Sinai School of Medicine

Study Dates

Start Date:January 2008
Completion Date:March 2009
Completion Type:Actual
Primary Completion Date:January 2009
Primary Completion Type:Actual
Verification Date:November 2014
Last Changed Date:November 14, 2014
First Received Date:November 28, 2007

Study Outcomes

Outcome Type:Primary Outcome
Measure:Treatment sucess based on patients' glycemic control
Time Frame:12 Months
Safety Issues:False

Study Interventions

Intervention Type:Procedure
Name:Surgical Treatment
Description:Ileal transposition with sleeve gastrectomy
Arm Name:Ileal transposition with SG

Study Arms

Study Arm Type:Experimental
Arm Name:Ileal transposition with SG
Description:Procedure: Surgical Treatment

Study Agencies

Agency Class:Industry
Agency Type:Lead Sponsor
Agency Name:Covidien

Sample and Retention Information

There are no available Sample and Retention Information

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

This study is not currently recruiting Study Participants. The form below is not enabled.